Michael Hulse

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 2

Top Topics

Cell Proliferation

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Cancer research

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jack Carter, Michael Hulse, Monisha Sivakumar, Jessica Burtell, Venkat Thodima, Min Wang, Anjana Agarwal, Komali Vykuntam, Jacob Spruance, Neha Bhagwat, Joseph Rager, Bruce A Ruggeri, Peggy Scherle, Koichi Ito
PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and Chemotherapies. Cancer research communications (2023)
Silvia Maifrede, Bac Viet Le, Margaret Nieborowska-Skorska, Konstantin Golovine, Katherine Sullivan-Reed, Wangisa M B Dunuwille, Joseph Nacson, Michael Hulse, Kelsey Keith, Jozef Madzo, Lisa Beatrice Caruso, Zachary Gazze, Zhaorui Lian, Antonella Padella, Kumaraswamy N Chitrala, Boris A Bartholdy, Ksenia Matlawska-Wasowska, Daniela Di Marcantonio, Giorgia Simonetti, Georg Greiner, Stephen M Sykes, Peter Valent, Elisabeth M Paietta, Martin S Tallman, Hugo F Fernandez, Mark R Litzow, Mark D Minden, Jian Huang, Giovanni Martinelli, George S Vassiliou, Italo Tempera, Katarzyna Piwocka, Neil Johnson, Grant A Challen, Tomasz Skorski
TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors. Cancer research 81 (19) (2021)